참고문헌 (90)

1. Fasano, A. (1998) Novel approaches in oral delivery of macromolecules. J. Pharm. Sci. 87: 1351-1356. 

   상세보기

2. Youn, Y. S., J. Y. Jung, S. H. Oh, S. D. Yoo, and K. C. Lee (2006) Improved intestinal delivery of salmon calcitonin by Lys18-amine specific PEGylation: Stability, permeability, pharmacokinetic behavior and in vivo hypocalcemic efficacy. J. Control Rel. 114: 334-342. 

   상세보기

3. Sugawara, M., S. Kadomura, X. He, Y. Takekuma, N. Kohri, and K. Miyazaki (2005) The use of an in vitro dissolution and absorption system to evaluate oral absorption of two weak bases in pH-independent controlled-release formulations. Eur. J. Pharm. Sci. 26: 1-8. 

   상세보기

4. Mayersohn, M. (2002) Modern Pharmaceutics. 4nd ed, pp. 23-66. Marcel Dekker, United states. 

5. Amidon, G. L., H. Lennernas, V. P. Shah, and J. R. Crison (1995) A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm. Res. 12: 413-420. 

   상세보기

6. Pouton, C. W. (2006) Formulation of poorly water-soluble drugs for oral administration: Physicochemical and physiological issues and the lipid formulation classification system. Eur. J. Pharm. Sci. 29: 278-287. 

   상세보기

7. Lindenberg, M. (2004) Classification of orally administered drugs on the World Health Organization Model list of Essential Medicines according to the biopharmaceutics classification system. Eur. J. Pharm. Biopharm. 58: 265-278. 

   상세보기

8. Hauss, D. J. (2007) Oral lipid-based formulations. Adv. Drug Del. Rev. 59: 667-676. 

   상세보기

9. Peltonen, L. and J. Hirvonen (2010) Pharmaceutical nanocrystals by nanomilling: critical process parameters, particle fracturing and stabilization methods. J. Pharm. Pharmacol. 62: 1569-1579. 

   상세보기

10. Liversidge, G. G. (1995) Particle size reduction for improvement of oral bioavailability of hydrophobic drugs: I. Absolute oral bioavailability of nanocrystalline danazol in beagle dogs. Int. J. Pharm. 125: 91-97. 

    상세보기

11. Yeo, S.-D., G.-B. Lim, P. G. Debendetti, and H. Bernstein (1993) Formation of microparticulate protein powder using a supercritical fluid antisolvent. Biotechnol. Bioeng. 41: 341-346. 

    상세보기

12. Jinno, J., N. Kamada, M. Miyake, K. Yamada, T. Mukai, M. Odomi, H. Toguchi, G. G. Liversidge, K. Higaki, and T. Kimura (2006) Effect of particle size reduction on dissolution and oral absorption of a poorly water-soluble drug, cilostazol, in beagle dogs. J. Control. Rel. 111: 56-64. 

    상세보기

13. Shafiq, S., F. Shakeel, S. Talegaonkar, F. J. Ahmad, R. K. Khar, and M. Ali (2007) Development and bioavailability assessment of ramipril nanoemulsion formulation. Eur. J. Pharm. Biopharm. 66: 227-243. 

    상세보기

14. Nepal, P. R., H.-K. Han, and H.-K. Choi (2010) Preparation and in vitro-in vivo evaluation of $Witepsol^{\circledR}$ H35 based selfnanoemulsifying drug delivery systems (SNEDDS) of coenzyme Q10. Eur. J. Pharm. Sci. 39: 224-232. 

    상세보기

15. Tiwari, R. and K. Pathak (2011) Nanostructured lipid carrier versus solid lipid nanoparticles of simvastatin: Comparative analysis of characteristics, pharmacokinetics and tissue uptake. Int. J. Pharm. 415: 232-243. 

    상세보기

16. Sekiguchi, K. and N. Obi (1961) Studies on absorption of eutectic mixture. I. a comparison of the behavior of eutectic mixture of sulfathiazole and that of ordinary sulfathiazole in man. Chem. Pharm. Bull. 9: 866-872. 

    상세보기

17. Chiou, W. L. and S. Riegelman (1971) Pharmaceutical applications of solid dispersion systems. J. Pharm. Sci. 60: 1281-1302. 

    상세보기

18. Corrigan, O. I. (1985) Mechanisms of dissolution of fast release solid dispersions. Drug Dev. Ind. Pharm. 11: 697-724. 

    상세보기

19. Yonemochi, E., S. Kitahara, S. Maeda, S. Yamamura, T. Oguchi, and K. Yamamoto (1999) Physicochemical properties of amorphous clarithromycin obtained by grinding and spray drying. Eur. J. Pharm. Sci. 7: 331-338. 

    상세보기

20. Chow, A. H. L., C. K. Hsia, J. D. Gordon, J. W. M. Young, and E. I. Vargha-Butler (1995) Assessment of wettability and its relationship to the intrinsic dissolution rate of doped phenytoin crystals. Int. J. Pharm. 126: 21-28. 

    상세보기

21. Yonemochi, E., Y. Ueno, T. Ohmae, T. Oguchi, S.-i. Nakajima, and K. Yamamoto (1997) Evaluation of amorphous ursodeoxycholic acid by thermal methods. Pharm. Res. 14: 798-803. 

    상세보기

22. Kim, E.-J., M.-K. Chun, J.-S. Jang, I.-H. Lee, K.-R. Lee, and H.-K. Choi (2006) Preparation of a solid dispersion of felodipine using a solvent wetting method. Eur. J. Pharm. Biopharm. 64: 200-205. 

    상세보기

23. Joshi, H. N., R. W. Tejwani, M. Davidovich, V. P. Sahasrabudhe, M. Jemal, M. S. Bathala, S. A. Varia, and A. T. M. Serajuddin (2004) Bioavailability enhancement of a poorly water-soluble drug by solid dispersion in polyethylene glycol-polysorbate 80 mixture. Int. J. Pharm. 269: 251-258. 

    상세보기

24. Nepal, P. R., H. K. Han, and H. K. Choi (2010) Enhancement of solubility and dissolution of coenzyme Q10 using solid dispersion formulation. Int. J. Pharm. 383: 147-153. 

    상세보기

25. Serajuddin, A. T. (1999) Solid dispersion of poorly water-soluble drugs: early promises, subsequent problems, and recent breakthroughs. J. Pharm. Sci. 88: 1058-1066. 

    상세보기

26. Goldberg, A. H., M. Gibaldi, and J. L. Kanig (1966) Increasing dissolution rates and gastrointestinal absorption of drugs via solid solutions and eutectic mixtures II: Experimental evaluation of a eutectic mixture: Urea-acetaminophen system. J. Pharm Sci. 55: 482-487. 

    상세보기

27. Goldberg, A. H., M. Gibaldi, J. L. Kanig, and M. Mayersohn (1966) Increasing dissolution rates and gastrointestinal absorption of drugs via solid solutions and eutectic mixtures IV: Chloramphenicol-urea system. Journal of Pharmaceutical Sciences 55: 581-583 

    상세보기

28. Kanig, J. L. (1964) Properties of fused mannitol in compressed tablets. J. Pharm. Sci. 53: 188-192. 

    상세보기

29. Levy, G. (1963) Effect of particle size on dissolution and gastrointestinal absorption rates of pharmaceuticals. Am. J. Pharm. 135: 78-92. 

30. Goldberg, A. H., M. Gibaldi, J. L. Kanig, and M. Mayersohn (1966) Increasing dissolution rates and gastrointestinal absorption of drugs via solid solutions and eutectic mixtures IV: Chloramphenicol-urea system. J. Pharm. Sci. 55: 581-583. 

    상세보기

31. Chiou, W. L. and S. Riegelman (1969) Preparation and dissolution characteristics of several fast-release solid dispersions of griseofulvin. J. Pharm. Sci. 58: 1505-1510. 

    상세보기

32. Najib, N. M., M. Suleiman, and A. Malakh (1986) Characteristics of the in vitro release of ibuprofen from polyvinylpyrrolidone solid dispersions. Int. J. Pharm. 32: 229-236. 

    상세보기

33. Ford, J. L., A. F. Stewart, and J.-L. Dubois (1986) The properties of solid dispersions of indomethacin or phenylbutazone in polyethylene glycol. Int. J. Pharm. 28: 11-22. 

    상세보기

34. Ho, H.-O., H.-L. Su, T. Tsai, and M.-T. Sheu (1996) The preparation and characterization of solid dispersions on pellets using a fluidized-bed system. Int. J. Pharm. 139: 223-229. 

    상세보기

35. Simonelli, A. P., S. C. Mehta, and W. I. Higuchi (1969) Dissolution rates of high energy polyvinylpyrrolidone (PVP)-sulfathiazole coprecipitates. J. Pharm. Sci. 58: 538-549. 

    상세보기

36. Taylor, L. S. and G. Zografi (1997) Spectroscopic characterization of interactions between PVP and indomethacin in amorphous molecular dispersions. Pharm. Res. 14: 1691-1698. 

    상세보기

37. Leuner, C. and J. Dressman (2000) Improving drug solubility for oral delivery using solid dispersions. Eur. J. Pharm. Biopharm. 50: 47-60. 

    상세보기

38. Konno, H., T. Handa, D. E. Alonzo, and L. S. Taylor (2008) Effect of polymer type on the dissolution profile of amorphous solid dispersions containing felodipine. Eur. J. Pharm. Biopharm. 70: 493-499. 

    상세보기

39. Vasconcelos, T., B. Sarmento, and P. Costa (2007) Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs. Drug Dis. Today 12: 1068-1075. 

    상세보기

40. van Drooge, D. J., W. L. J. Hinrichs, M. R. Visser, and H. W. Frijlink (2006) Characterization of the molecular distribution of drugs in glassy solid dispersions at the nano-meter scale, using differential scanning calorimetry and gravimetric water vapour sorption techniques. Int. J. Pharm. 310: 220-229. 

    상세보기

41. Mura, P., M. T. Faucci, A. Manderioli, G. Bramanti, and P. Parrini (1999) Thermal behavior and dissolution properties of naproxen from binary and ternary solid dispersions. Drug Dev. Ind. Pharm. 25: 257-264. 

    상세보기

42. Li, F.-Q., J.-H. Hu, J.-X. Deng, H. Su, S. Xu, and J.-Y. Liu (2006) In vitro controlled release of sodium ferulate from Compritol 888 ATO-based matrix tablets. Int. J. Pharm. 324: 152-157. 

    상세보기

43. Karatas, A., N. Yuksel, and T. Baykara (2005) Improved solubility and dissolution rate of piroxicam using gelucire 44/14 and labrasol. Farmaco 60: 777-782. 

    상세보기

44. Chauhan, B., S. Shimpi, and A. Paradkar (2005) Preparation and evaluation of glibenclamide-polyglycolized glycerides solid dispersions with silicon dioxide by spray drying technique. Eur. J. Pharm. Sci. 26: 219-230. 

    상세보기

45. Yuksel, N., A. Karatas, Y. Ozkan, A. Savaser, S.A. Ozkan, and T. Baykara (2003) Enhanced bioavailability of piroxicam using Gelucire 44/14 and Labrasol: in vitro and in vivo evaluation. Eur. J. Pharm. Biopharm. 56: 453-459. 

    상세보기

46. Mura, P., J. R. Moyano, M. L. Gonzalez-Rodriguez, A. M. Rabasco- Alvarez, M. Cirri, and F. Maestrelli (2005) Characterization and dissolution properties of detoprofen in binary and ternary solid dispersions with polyethylene glycol and surfactants. Drug Dev. Ind. Pharm. 31: 425-434. 

    상세보기

47. Law, S. L., W. Y. Lo, F. M. Lin, and C. H. Chaing (1992) Dissolution and absorption of nifedipine in polyethylene glycol solid dispersion containing phosphatidylcholine. Int. J. Pharm. 84: 161-166. 

    상세보기

48. Hirasawa, N., S. Ishise, H. Miyata, and K. Danjo (2003) An attempt to stabilize nilvadipine solid dispersion by the use of ternary systems. Drug Dev. Ind. Pharm. 29: 997-1004. 

    상세보기

49. Stoll, R. G., T. R. Bates, K. A. Nieforth, and J. Swarbrick (1969) Some physical factors affecting the enhanced blepharoptotic activity of orally administered reserpine-cholanic acid coprecipitates. J. Pharm. Sci. 58: 1457-1459. 

    상세보기

50. Yamamura, S. and J. A. Rogers (1996) Characterization and dissolution behavior of nifedipine and phosphatidylcholine binary systems. Int. J. Pharm. 130: 65-73. 

    상세보기

51. Kennedy, M., J. Hu, P. Gao, L. Li, A. Ali-Reynolds, B. Chal, V. Gupta, C. Ma, N. Mahajan, A. Akrami, and S. Surapaneni (2008) Enhanced Bioavailability of a Poorly Soluble VR1 Antagonist Using an Amorphous Solid Dispersion Approach: A Case Study. Molecular Pharmaceutics 5: 981-993. 

    상세보기

52. Simonelli, A. P., S. C. Metha, and W. I. Higuchi (1976) Dissolution rates of high energy sulfathiazide-povidone coprecipitates II: characterization of form of drug controlling its dissolution rate via solubility studies. J. Pharm. Sci. 65: 355-360. 

    상세보기

53. Matsumoto, T. and G. Zografi (1999) Physical properties of solid molecular dispersions of indomethacin with poly(vinylpyrrolidone) and poly(vinylpyrrolidone-co-vinyl-acetate) in relation to indomethacin crystallization. Pharm. Res. 16: 1722-1728. 

    상세보기

54. Hasegawa, A., M. Taguchi, R. Suzuki, T. Miyata, H. Nakagawa, and I. Sugimoto (1988) Supersaturation mechanism of drugs from solid dispersions with enteric coating agents. Chem. Pharm. Bull. 36: 4941-4950. 

    상세보기

55. Suzuki, H. and H. Sunada (1998) Influence of water-soluble polymers on the dissolution of nifedipine solid dispersions with combined carriers. Chem. Pharm. Bull. 46: 482-487. 

    상세보기

56. Hasegawa, A., R. Kawamura, H. Nakagawa, and I. Sugimoto (1985) Dissolution mechanism of solid dispersions of nifedipine with enteric coating agents. J. Pharm. Sci. Technol. Jpn. 106: 586-592. 

57. Yamashita, K., T. Nakate, K. Okimoto, A. Ohike, Y. Tokunaga, R. Ibuki, K. Higaki, and T. Kimura (2003) Establishment of new preparation method for solid dispersion formulation of tacrolimus. Int. J. Pharm. 267: 79-91. 

    상세보기

58. Tiwari, R., G. Tiwari, B. Srivastava, and A.K. Rai (2009) Solid dispersions: an overview to modify bioavailability of poorly water soluble drugs. Int. J. Pharm. Tech. Res. 1: 1388-1449. 

59. McGinity, J. W., P. Maincent, and H. Steinfink (1984) Crystallinity and dissolution rate of tolbutamide solid dispersions prepared by the melt method. J. Pharm. Sci. 73: 1441-1444. 

    상세보기

60. Sekiguchi, K., N. Obi, and Y. Ueda (1964) Studies on absorption of eutectic mixtures. II. Absorption of fused conglomerates of chloramphenicol and urea in rabbits. Chem. Pharm. Bull. 12: 134-144. 

    상세보기

61. Allen, L. V., R. S. Levinson, and D. De Martono (1978) Dissolution rates of hydrocortisone and prednisone utilizing sugar solid dispersion systems in tablet form. J. Pharm. Sci. 67: 979-981. 

    상세보기

62. Yao, W.-W., T.-C. Bai, J.-P. Sun, C.-W. Zhu, J. Hu, and H.-L. Zhang (2005) Thermodynamic properties for the system of silybin and poly(ethylene glycol) 6000. Thermochim. Acta 437: 17-20. 

    상세보기

63. Sheen, P.-C., A. R. Nanda, C. E. Rowlings, and N. P. Barker (2000) Water-Insoluble Drug Formulation. 1st ed, pp. 493-523. Interpharm Press, United states. 

64. Speiser, P. (1966) Galenische aspekte der arzneimittelwirkung. Pharm. Acta Helv. 41: 321-342. 

    상세보기

65. Huttenrauch, R. (1974) Spritzgiessverfahren zur herstellung peroraler retardpraperate. Pharmazie 29: 297-302. 

    상세보기

66. Verreck, G., A. Decorte, K. Heymans, J. Adriaensen, D. Liu, D. Tomasko, A. Arien, J. Peeters, G. Van den Mooter, and M. E. Brewster (2006) Hot stage extrusion of p-amino salicylic acid with EC using CO2 as a temporary plasticizer. Int. J. pharm. 327: 45-50. 

    상세보기

67. Verreck, G., A. Decorte, K. Heymans, J. Adriaensen, D. Liu, D. L. Tomasko, A. Arien, J. Peeters, P. Rombaut, G. Van den Mooter, and M. E. Brewster (2007) The effect of supercritical CO2 as a reversible plasticizer and foaming agent on the hot stage extrusion of itraconazole with EC 20 J. Supercrit. Fluids 40: 153-162. 

    상세보기

68. DiNunzio, J. C., C. Brough, D. A. Miller, R. O. Williams, and J. W. McGinity (2010) Fusion processing of itraconazole solid dispersions by $kinetisol^{\circledR}$ dispersing: A comparative study to hot melt extrusion. J. Pharm. Sci. 99: 1239-1253. 

    상세보기

69. Tachibana, T. and A. Nakamura (1965) A methode for preparing an aqueous colloidal dispersion of organic materials by using water-soluble polymers: Dispersion of B-carotene by polyvinylpyrrolidone. Colloid Polym. Sci. 203: 130-133. 

70. Karavas, E., E. Georgarakis, and D. Bikiaris (2006) Application of PVP/HPMC miscible blends with enhanced mucoadhesive properties for adjusting drug release in predictable pulsatile chronotherapeutics. Eur. J. Pharm. Biopharm. 64: 115-126. 

    상세보기

71. Wang, X., A. Michoel, and G. Van den Mooter (2005) Solid state characteristics of ternary solid dispersions composed of PVP VA64, Myrj 52 and itraconazole. Int. J. Pharm. 303: 54-61. 

    상세보기

72. Desai, J., K. Alexander, and A. Riga (2006) Characterization of polymeric dispersions of dimenhydrinate in ethyl cellulose for controlled release. Int. J. Pharm. 308: 115-123. 

    상세보기

73. Ceballos, A., M. Cirri, F. Maestrelli, G. Corti, and P. Mura (2005) Influence of formulation and process variables on in vitro release of theophylline from directly-compressed Eudragit matrix tablets. Il Farmaco 60: 913-918. 

    상세보기

74. Prabhu, S., M. Ortega, and C. Ma (2005) Novel lipid-based formulations enhancing the in vitro dissolution and permeability characteristics of a poorly water-soluble model drug, piroxicam. Int. J. Pharm. 301: 209-216. 

    상세보기

75. Van den Mooter, G., I. Weuts, T. De Ridder, and N. Blaton (2006) Evaluation of Inutec SP1 as a new carrier in the formulation of solid dispersions for poorly soluble drugs. Int. J. Pharm. 316: 1-6. 

    상세보기

76. Jung, J.-Y., S. D. Yoo, S.-H. Lee, K.-H. Kim, D.-S. Yoon, and K.-H. Lee (1999) Enhanced solubility and dissolution rate of itraconazole by a solid dispersion technique. Int. J. Pharm. 187: 209-218. 

    상세보기

77. Won, D. H. (2005) Improved physicochemical characteristics of felodipine solid dispersion particles by supercritical anti-solvent precipitation process. Int. J. Pharm. 301: 199-208. 

    상세보기

78. Dhirendra, K., S. Lewis, N. Udupa, and K. Atin (2009) Solid dispersions: a review. Pak. J. Pharm. Sci. 22: 234-246. 

    상세보기

79. Weuts, I., D. Kempen, G. Verreck, A. Decorte, K. Heymans, J. Peeters, M. Brewster, and G. V. d. Mooter (2005) Study of thephysicochemical properties and stability of solid dispersions of loperamide and PEG6000 prepared by spray drying. Eur. J. Pharm. Biopharm. 59: 119-126. 

    상세보기

80. van Drooge, D.-J., W. L. J. Hinrichs, B. H. J. Dickhoff, M. N. A. Elli, M. R. Visser, G. S. Zijlstra, and H. W. Frijlink (2005) Spray freeze drying to produce a stable [Delta]9- tetrahydrocannabinol containing inulin-based solid dispersion powder suitable for inhalation. Eur. J. Pharm. Sci. 26: 231-240. 

    상세보기

81. Park, Y.-J., D.-S. Ryu, D. X. Li, Q. Z. Quan, D. H. Oh, J. O. Kim, Y. G. Seo, Y.-I. Lee, C. S. Yong, J. S. Woo, and H.-G. Choi (2009) Physicochemical characterization of tacrolimus-loaded solid dispersion with sodium carboxylmethyl cellulose and sodium lauryl sulphate. Arch. Pharm. Res. 32: 893-898. 

    원문보기 상세보기

82. Park, Y.-J., D.-H. Oh, Y.-D. Yan, Y.-G. Seo, S.-N. Lee, H.-G. Choi, and C.-S. Yong (2010) Surface-attached solid dispersion. J. Pharm. Inv. 40: 103-112. 

    원문보기 상세보기

83. Joe, J. H., W. M. Lee, Y.-J. Park, K. H. Joe, D. H. Oh, Y. G. Seo, J. S. Woo, C. S. Yong, and H.-G. Choi (2010) Effect of the solid-dispersion method on the solubility and crystalline property of tacrolimus. Int. J. Pharm. 395: 161-166. 

    상세보기

84. Kerc, J. and S. Srcic (1995) Thermal analysis of glassy pharmaceuticals. Thermochim. Acta 248: 81-95. 

    상세보기

85. Kreuter, J. (1999) Grundlagen der Arzneiformenlehre. pp. 262-274. Springer, Germany. 

86. Van den Mooter, G., M. Wuyts, N. Blaton, R. Busson, P. Grobet, P. Augustijns, and R. Kinget (2001) Physical stabilisation of amorphous ketoconazole in solid dispersions with polyvinylpyrrolidone K25. Eur. J. Pharm. Sci. 12: 261-269. 

    상세보기

87. Klug, H. P. and L. E. Alexander (1974) X-ray diffraction procedures for polycrystalline and amorphous materials. 2nd ed, pp. 55-58. Wiley, New York. 

88. Karagiannidis, P. G., A. C. Stergiou, and G. P. Karayannidis (2008) Study of crystallinity and thermomechanical analysis of annealed poly(ethylene terephthalate) films. Eur. Polym. J. 44: 1475-1486. 

    상세보기

89. Tran, P., T. Tran, J. Park, and B.-J. Lee (2011) Controlled release systems containing solid dispersions: strategies and mechanisms. Pharm. Res. 1-26. 

90. Yoshioka, M., B. C. Hancock, and G. Zografi (1995) Inhibition of indomethacin crystallization in poly(vinylpyrrolidone) coprecipitates. J. Pharm. Sci. 84: 983-986. 

    상세보기

저자의 다른 논문 :

조훈 (27) 최후균 (40)